BiotechTube
Home/Prolifagen Therapeutics/Will Houston
WH

Will Houston

Chief Financial Officer

Prolifagen Therapeutics

Therapeutic Areas

Cardiovascular DiseaseMyocardial Infarction

Prolifagen Therapeutics Pipeline

DrugIndicationPhase
PRO302Heart muscle regeneration post-myocardial infarctionPreclinical

Leadership Team at Prolifagen Therapeutics

MB
Mike Behr
Chief Executive Officer
KS
Kiernan Seth
Chief Development Officer
AB
Andreas Bader
Consultant Chief Science Officer
CB
Claudine Bruck
Co-Founder & Board Chair
View full Prolifagen Therapeutics profile